Clinical safety of the selective PKC-beta inhibitor, ruboxistaurin.
Expert Opin Drug Saf. 2006 Nov;5(6):835-45. doi: 10.1517/14740338.5.6.835.
Expert Opin Drug Saf. 2006.
PMID: 17044810
Review.